Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation

Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte... Moreno et al. Multiple Sclerosis and Demyelinating Disorders (2019) 4:3 Multiple Sclerosis and https://doi.org/10.1186/s40893-019-0040-7 Demyelinating Disorders CORRECTION Open Access Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation 1,2 1 1 1 1,3 1 Beatriz Moreno , Gemma Vila , Begoña Fernandez-Diez , Raquel Vázquez , Alessandra di Penta , Oihana Errea , 1 4 4 1,5,6* Nagore Escala , Andrés Miguez , Jordi Alberch and Pablo Villoslada Correction to: Multiple Sclerosis and Demyelinating Disorders (2017) 2:3. https://doi.org/10.1186/s40893-017-0020-8 After publication of the article [1], it has been brought to our attention that the full funding acknowledgement is missing from the original article. It should also include the following – “This work was supported by the Instituto de Salud Carlos III with FEDER funds (Otra forma de hacer Europa) from the European Commission (FIS: PI12/01823)”. Author details Center of Neuroimmunology, Institut d’Investigacions Biomediques August Pi Sunyer (IDIBAPS), Barcelona, Spain. Department of Basic Sciences, Facultad de Medicina i Ciències de la Salut, Universitat International de Catalunya (UIC), Sant Cugat del Vallés, Spain. Neurogenomiks, University of Basque Country, Leioa, Spain. University of Barcelona, Barcelona, Spain. 5 6 University of California, San Francisco, USA. Centre Cellex 3A, Casanova 145, 08036 Barcelona, Spain. Received: 22 February 2019 Accepted: 22 February 2019 Reference 1. Moreno B, Vila G, Fernandez-Diez B, Vázquez R, di Penta A, Errea O, et al. Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation. Multiple Sclerosis and Demyelinating Disorders. 2017;2(1). * Correspondence: pvilloslada@clinic.ub.es; Pablo.VillosladaDiaz@ucsf.edu Center of Neuroimmunology, Institut d’Investigacions Biomediques August Pi Sunyer (IDIBAPS), Barcelona, Spain University of California, San Francisco, USA © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Multiple Sclerosis and Demyelinating Disorders Springer Journals

Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation

Free
Download PDF
1 page

Loading next page...
 
/lp/springer-journals/correction-to-methylthioadenosine-promotes-remyelination-by-inducing-QTP0s8W3u3
Publisher
Springer Journals
Copyright
Copyright © 2019 by The Author(s).
Subject
Medicine & Public Health; Neurology; Rehabilitation Medicine
eISSN
2056-6115
DOI
10.1186/s40893-019-0040-7
Publisher site
See Article on Publisher Site

Abstract

Moreno et al. Multiple Sclerosis and Demyelinating Disorders (2019) 4:3 Multiple Sclerosis and https://doi.org/10.1186/s40893-019-0040-7 Demyelinating Disorders CORRECTION Open Access Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation 1,2 1 1 1 1,3 1 Beatriz Moreno , Gemma Vila , Begoña Fernandez-Diez , Raquel Vázquez , Alessandra di Penta , Oihana Errea , 1 4 4 1,5,6* Nagore Escala , Andrés Miguez , Jordi Alberch and Pablo Villoslada Correction to: Multiple Sclerosis and Demyelinating Disorders (2017) 2:3. https://doi.org/10.1186/s40893-017-0020-8 After publication of the article [1], it has been brought to our attention that the full funding acknowledgement is missing from the original article. It should also include the following – “This work was supported by the Instituto de Salud Carlos III with FEDER funds (Otra forma de hacer Europa) from the European Commission (FIS: PI12/01823)”. Author details Center of Neuroimmunology, Institut d’Investigacions Biomediques August Pi Sunyer (IDIBAPS), Barcelona, Spain. Department of Basic Sciences, Facultad de Medicina i Ciències de la Salut, Universitat International de Catalunya (UIC), Sant Cugat del Vallés, Spain. Neurogenomiks, University of Basque Country, Leioa, Spain. University of Barcelona, Barcelona, Spain. 5 6 University of California, San Francisco, USA. Centre Cellex 3A, Casanova 145, 08036 Barcelona, Spain. Received: 22 February 2019 Accepted: 22 February 2019 Reference 1. Moreno B, Vila G, Fernandez-Diez B, Vázquez R, di Penta A, Errea O, et al. Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation. Multiple Sclerosis and Demyelinating Disorders. 2017;2(1). * Correspondence: pvilloslada@clinic.ub.es; Pablo.VillosladaDiaz@ucsf.edu Center of Neuroimmunology, Institut d’Investigacions Biomediques August Pi Sunyer (IDIBAPS), Barcelona, Spain University of California, San Francisco, USA © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Journal

Multiple Sclerosis and Demyelinating Disorders – Springer Journals

Published: Apr 23, 2019

There are no references for this article.